Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 610786, 5 pages
http://dx.doi.org/10.1155/2013/610786
Clinical Study

Preoperative Chemoradiotherapy in Elderly Patients with Locally Advanced Rectal Cancer

1Department of Radiotherapy, Policlinico Umberto I “Sapienza” University of Rome, Viale Regina Elena 326, 00161 Rome, Italy
2Department of Surgery “Pietro Valdoni”, Policlinico Umberto I “Sapienza” University of Rome, Viale Regina Elena 326, 00161 Rome, Italy
3Spencer-Lorillard Foundation, Viale Regina Elena 262, 00161 Rome, Italy

Received 2 August 2013; Accepted 4 December 2013

Academic Editor: Steven N. Hochwald

Copyright © 2013 Francesca De Felice et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. L. Gunderson, D. J. Sargent, J. E. Tepper et al., “Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis,” International Journal of Radiation Oncology Biology Physics, vol. 54, no. 2, pp. 386–396, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. H. J. Schmoll, E. Van Cutsem, A. Stein et al., “ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making,” Annals of Oncology, vol. 23, no. 10, pp. 2479–2516, 2012. View at Google Scholar
  3. C. Rödel, T. Liersch, H. Becker et al., “Preparative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial Rectal Cancer Study Group,” The Lancet Oncology, vol. 13, pp. 679–687, 2012. View at Google Scholar
  4. C. Aschele, L. Cionini, S. Lonardi et al., “Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial,” Journal of Clinical Oncology, vol. 29, no. 20, pp. 2773–2780, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J.-P. Gérard, D. Azria, S. Gourgou-Bourgade et al., “Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial accord 12/0405-Prodige 2,” Journal of Clinical Oncology, vol. 28, no. 10, pp. 1638–1644, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. S. Roh, G. A. Yothers, M. J. O'Connell et al., “The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04,” Journal of Clinical Oncology, vol. 29, 2011, abstract: 3503. View at Google Scholar
  7. X. An, X. Lin, F. H. Wang et al., “Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis,” European Journal of Cancer, vol. 49, no. 4, pp. 843–851, 2013. View at Publisher · View at Google Scholar
  8. D. Musio, F. De Felice, N. Bulzonetti et al., “Neoadjuvant-intensified treatment for rectal cancer: time to change?” World Journal of Gastroenterology, vol. 19, no. 20, pp. 3052–3061, 2013. View at Google Scholar
  9. D. Papamichael, R. Audisio, J.-C. Horiot et al., “Treatment of the elderly colorectal cancer patient: SIOG expert recommendations,” Annals of Oncology, vol. 20, no. 1, pp. 5–16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Edge, D. Byrd, C. Compton et al., Eds., AJCC Cancer Staging Manual, Springer, New York, NY, USA, 7th edition, 2009.
  11. J. F. Piccirillo, R. M. Tierney, I. Costas, L. Grove, and E. L. Spitznagel Jr., “Prognostic importance of comorbidity in a hospital-based cancer registry,” The Journal of the American Medical Association, vol. 291, no. 20, pp. 2441–2447, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. M. M. Oken, R. H. Creech, D. C. Tormey et al., “Toxicity and response criteria of the Eastern Cooperative Oncology Group,” American Journal of Clinical Oncology, vol. 5, no. 6, pp. 649–655, 1982. View at Google Scholar
  13. Cancer Therapy Evaluation Program, “Common Terminology Criteria for Adverse Events, Version 3.0,” 2006, http://ctep.cancer.gov/.
  14. N. Howlader, A. M. Noone, M. Krapcho et al., Eds., SEER Cancer Statistics Review, 1975–2010, National Cancer Institute, Bethesda, Md, USA, April 2013, http://seer.cancer.gov/csr/1975_2010/.
  15. A. Bolognese and L. Izzo, Surgery in Multimodal Management of Solid Tumour, Springer, Milano, Italy, 2008.
  16. R. Sauer, H. Becker, W. Hohenberger et al., “Preoperative versus postoperative chemoradiotherapy for rectal cancer,” The New England Journal of Medicine, vol. 351, no. 17, pp. 1731–1740, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Havenga, I. Grossmann, M. DeRuiter, and T. Wiggers, “Definition of total mesorectal excision, including the perineal phase: technical considerations,” Digestive Diseases, vol. 25, no. 1, pp. 44–50, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Bolognese, L. Izzo, F. Pugliese, and P. Di Cello, Il Tumore del Colon Nell’era delle Terapie Personalizzate: Il Ruolo della Chirurgia Nella Malattia Metastatica, Verduci, 2012.
  19. A. Bolognese, M. Cardi, I. A. Muttillo, A. Barbarosos, T. Bocchetti, and S. Valabrega, “Total mesorectal excision for surgical treatment of rectal cancer,” Journal of Surgical Oncology, vol. 74, no. 1, pp. 21–23, 2000. View at Google Scholar · View at Scopus
  20. P. Piso, M.-H. Dahlke, P. Mirena et al., “Total mesorectal excision for middle and lower rectal cancer: a single institution experience with 337 consecutive patients,” Journal of Surgical Oncology, vol. 86, no. 3, pp. 115–121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. J.-F. Bosset, L. Collette, G. Calais et al., “Chemotherapy with preoperative radiotherapy in rectal cancer,” The New England Journal of Medicine, vol. 355, no. 11, pp. 1114–1123, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. J.-P. Gérard, T. Conroy, F. Bonnetain et al., “Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203,” Journal of Clinical Oncology, vol. 24, no. 28, pp. 4620–4625, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Rondelli, P. Reboldi, A. Rulli et al., “Loop ileostomy versus loop colostomy for fecal diversion after colorectal or coloanal anastomosis: a meta-analysis,” International Journal of Colorectal Disease, vol. 24, no. 5, pp. 479–488, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Berretta, A. Cappellani, F. Fiorica et al., “FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: a prospective study,” Archives of Gerontology and Geriatrics, vol. 52, no. 1, pp. 89–93, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Tougeron, B. Roullet, B. Paillot et al., “Safety and outcome of chemoradiotherapy in elderly patients with rectal cancer: results from two French tertiary centres,” Digestive and Liver Disease, vol. 44, no. 4, pp. 350–354, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Ausili Cèfaro, D. Genovesi, A. Vinciguerra et al., “Effects of preoperative radiochemotherapy with capecitabine for resectable locally advanced rectal cancer in elderly patients,” Tumori, vol. 98, no. 5, pp. 622–629, 2012. View at Google Scholar
  27. D. N. Margalit, H. J. Mamon, M. Ancukiewicz et al., “Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older,” International Journal of Radiation Oncology Biology Physics, vol. 81, no. 5, pp. e735–e741, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Cai, H. Wu, J. Peng et al., “Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older,” Radiation Oncology, vol. 8, article 86, 2013. View at Publisher · View at Google Scholar